Comments
Granules India on Friday informed the exchanges that its Bonthapally facility (Hyderabad, Telangana) has been issued one observation following an inspection by the USFDA.
The US Food and Drug Administration inspected the facility from July 22 to 26 and handed out one observation which is ‘procedural in nature’. The company will respond to this observation within the stipulated time. Shareholders of Granules will monitor the development.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.